Massachusetts Patent of the Month – April 2023

Learning is a lifelong process, and with the advent of technology, it has become even easier and more convenient for many. However, not all individuals learn at the same pace, and there is a need for personalized learning that caters to an individual’s unique needs. Understanding this unmet need, Constant Therapy Health has developed a personalized assessment and learning system that is tailored to meet the needs of each individual.

Constant Therapy Health provides a language, cognition, and skill (LCS) learning system that performs a range of tasks to assess and improve an individual’s LCS abilities. The system uses a personalized assessment and learning system equipped with task-selection protocols to select LCS-based tasks to be performed by the user. These tasks are generated and selected based on the administrator’s suggested learning regimen, while also adapting the selection of tasks and task content based on the user’s performance and/or context when the user is not being supervised by an administrator.

Constant Therapy Health provides personalized learning that takes into account the user’s medical conditions and preferences, offering cognitive, language, and skill learning tasks that cater to different learning abilities. This AI solution is at the core of Constant Therapy Health’s products, including their award-winning cognitive therapy platform called Constant Therapy. 

The evidence generated from their Constant Therapy platform forms the basis of numerous randomized clinical trials and informs the company’s broader clinical approach. The company has a number of ongoing research projects with investigations in Central Nervous System (CNS) disorders involving speech, language, and cognitive deficits including acquired brain injuries (stroke, TBI), mild cognitive impairment, mild Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and epilepsy. 

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts